Form 8-K - Current report:
SEC Accession No. 0001104659-25-026392
Filing Date
2025-03-21
Accepted
2025-03-21 07:01:01
Documents
16
Period of Report
2025-03-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm259925d1_8k.htm   iXBRL 8-K 28700
2 EXHIBIT 99.1 tm259925d1_ex99-1.htm EX-99.1 16706
3 EXHIBIT 99.2 tm259925d1_ex99-2.htm EX-99.2 7511
7 GRAPHIC tm259925d1_ex99-2001.jpg GRAPHIC 2304740
  Complete submission text file 0001104659-25-026392.txt   3410436

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tmb-20250321.xsd EX-101.SCH 3012
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmb-20250321_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmb-20250321_pre.xml EX-101.PRE 22358
18 EXTRACTED XBRL INSTANCE DOCUMENT tm259925d1_8k_htm.xml XML 3553
Mailing Address 12 PENNS TRAIL NEWTOWN PA 18940
Business Address 12 PENNS TRAIL NEWTOWN PA 18940 267-759-3680
Traws Pharma, Inc. (Filer) CIK: 0001130598 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36020 | Film No.: 25758502
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)